|
Volumn 246, Issue 11, 2008, Pages 1547-1551
|
Intravitreal injection of bevacizumab and gas for diabetic premacular hemorrhage with active fibrovascular proliferation
|
Author keywords
Bevacizumab; Diabetic premacular hemorrhage; Intravitreal gas
|
Indexed keywords
BEVACIZUMAB;
GLUCOSE;
HEMOGLOBIN A1C;
ABSENCE OF SIDE EFFECTS;
ACTIVE FIBROVASCULAR PROLIFERATION;
ADULT;
ARTICLE;
BLURRED VISION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIABETIC PREMACULAR HEMORRHAGE;
DIABETIC RETINOPATHY;
DIET RESTRICTION;
DISEASE ASSOCIATION;
FEMALE;
FOLLOW UP;
GAS;
HUMAN;
HUMAN TISSUE;
LASER COAGULATION;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RETINA DISEASE;
RISK REDUCTION;
TREATMENT DURATION;
VISUAL ACUITY;
VITREOUS OPACITY;
ADULT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CELL PROLIFERATION;
DIABETIC RETINOPATHY;
FEMALE;
FIBROSIS;
FUNDUS OCULI;
GASES;
HUMANS;
INJECTIONS;
MACULA LUTEA;
MALE;
MIDDLE AGED;
RETINAL HEMORRHAGE;
RETINAL VESSELS;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITREOUS BODY;
YOUNG ADULT;
|
EID: 54049155663
PISSN: 0721832X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00417-008-0902-8 Document Type: Article |
Times cited : (8)
|
References (10)
|